AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding AbCellera Biologics Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 144 | 1 | 138 | −5 |
| Shares | 108.4M | 176.4K | 124.3M | +16.0M (+14.8%) |
| Value | $370.6M | $603.2K | $434.0M | +$64.0M (+17.3%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jefferies Financial Group Inc. | 2,746,200 | $9.58M | 0.12% |
| Alyeska Investment Group, L.P. | 2,592,105 | $9.05M | 0.03% |
| Marshall Wace, LLP | 359,683 | $1.26M | 0.00% |
| SEB Asset Management AB | 340,267 | $1.19M | 0.01% |
| Simplex Trading, LLC | 201,236 | $702.3K | 0.02% |
| Axq Capital, LP | 136,227 | $475.4K | 0.06% |
| Quantbot Technologies LP | 34,536 | $120.5K | 0.00% |
| VestGen Advisors, LLC | 18,516 | $91.7K | 0.00% |
| SG Americas Securities, LLC | 20,200 | $70.0K | 0.00% |
| CIBC Bancorp USA Inc. | 20,000 | $69.8K | 0.00% |
| Brevan Howard Capital Management LP | 18,824 | $65.7K | 0.00% |
| Integrated Wealth Concepts LLC | 17,891 | $62.4K | 0.00% |
| Ground Swell Capital, LLC | 15,820 | $55.2K | 0.11% |
| Janney Montgomery Scott LLC | 13,043 | $46.0K | 0.00% |
| Vaughan David Investments LLC | 10,000 | $35.0K | 0.00% |
| Lantern Wealth Advisors, LLC | 10,000 | $34.9K | 0.02% |
| National Bank of Canada | 1,393 | $4.86K | 0.00% |
| National Asset Management, Inc. | 500 | $1.64K | 0.00% |
| Harbour Investments, Inc. | 127 | $443 | 0.00% |
| Gill Capital Partners, LLC | 100 | $349 | 0.00% |
Sold out (25)
Institutions that held AbCellera Biologics Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
Not filed for Q1 2026 yet (1)
Institutions that held AbCellera Biologics Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Norges Bank | 176,386 | $603.2K |